Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-06 1:58 pm Purchase | 2023-12-31 | 13G | Revance Therapeutics, Inc. RVNC | FRANKLIN RESOURCES INC BEN | 6,108,277 6.800% | 4,352,414 (+247.88%) | Filing History |
| 2024-01-25 1:48 pm Purchase | 2023-12-31 | 13G | Revance Therapeutics, Inc. RVNC | BlackRock Inc. BLK | 7,453,371 8.500% | 380,690 (+5.38%) | Filing History |
| 2024-01-25 11:11 am Unchanged | 2023-12-29 | 13G | Revance Therapeutics, Inc. RVNC | J P MORGAN CHASE & CO JPM | 4,754,771 5.400% | 0 (Unchanged) | Filing History |
| 2024-01-25 11:10 am Sale | 2023-12-29 | 13G | Revance Therapeutics, Inc. RVNC | J P MORGAN CHASE & CO JPM | 4,754,771 5.400% | -228,178 (-4.58%) | Filing History |
| 2023-10-24 4:05 pm Purchase | 2023-10-17 | 13D | Revance Therapeutics, Inc. RVNC | Teoxane SA | 6,550,800 7.400% | 2,105,000 (+47.35%) | Filing History |
| 2023-09-01 09:12 am Purchase | 2023-08-22 | 13D | Revance Therapeutics, Inc. RVNC | Teoxane SA | 4,445,800 5.000% | 4,445,800 (New Position) | Filing History |
| 2023-02-14 4:22 pm Purchase | 2022-12-31 | 13G | Revance Therapeutics, Inc. RVNC | Palo Alto Investors LLC | 5,283,609 6.420% | 914,243 (+20.92%) | Filing History |
| 2023-02-14 4:02 pm Purchase | 2022-12-31 | 13G | Revance Therapeutics, Inc. RVNC | Polar Capital Holdings Plc | 4,848,633 5.900% | 4,848,633 (New Position) | Filing History |
| 2023-02-14 07:33 am Purchase | 2022-12-31 | 13G | Revance Therapeutics, Inc. RVNC | Antara Capital LP | 5,239,600 6.400% | 5,239,600 (New Position) | Filing History |
| 2023-02-13 2:49 pm Purchase | 2023-02-14 | 13G | Revance Therapeutics, Inc. RVNC | Capital World Investors | 9,480,156 11.500% | 1,016,247 (+12.01%) | Filing History |
| 2023-02-09 2:10 pm Purchase | 2022-12-31 | 13G | Revance Therapeutics, Inc. RVNC | GOVERNMENT OF SINGAPORE INVESTMENT CORP PTE LTD | 5,492,965 6.680% | 1,316,885 (+31.53%) | Filing History |
| 2023-02-09 11:30 am Purchase | 2022-12-30 | 13G | Revance Therapeutics, Inc. RVNC | VANGUARD GROUP INC | 4,496,316 5.470% | 894,019 (+24.82%) | Filing History |
| 2023-02-03 4:27 pm Purchase | 2022-12-31 | 13G | Revance Therapeutics, Inc. RVNC | BlackRock Inc. BLK | 7,072,681 8.600% | 1,738,582 (+32.59%) | Filing History |
| 2023-01-27 12:22 pm Sale | 2022-12-30 | 13G | Revance Therapeutics, Inc. RVNC | J P MORGAN CHASE & CO JPM | 4,982,949 6.000% | -1,811,274 (-26.66%) | Filing History |
| 2022-12-09 1:58 pm Purchase | 2022-12-12 | 13G | Revance Therapeutics, Inc. RVNC | Capital World Investors | 8,463,909 10.300% | 4,751,909 (+128.01%) | Filing History |
| 2022-02-14 5:04 pm Purchase | 2021-12-31 | 13G | Revance Therapeutics, Inc. RVNC | Palo Alto Investors LLC | 4,369,366 6.090% | 4,369,366 (New Position) | Filing History |
| 2022-02-11 3:31 pm Purchase | 2022-02-14 | 13G | Revance Therapeutics, Inc. RVNC | Capital World Investors | 3,712,000 5.200% | 3,712,000 (New Position) | Filing History |
| 2022-02-10 08:32 am Purchase | 2021-12-31 | 13G | Revance Therapeutics, Inc. RVNC | VANGUARD GROUP INC | 3,602,297 5.020% | 3,602,297 (New Position) | Filing History |
| 2022-02-08 5:07 pm Purchase | 2021-12-31 | 13G | Revance Therapeutics, Inc. RVNC | GOVERNMENT OF SINGAPORE INVESTMENT CORP PTE LTD | 4,176,080 5.820% | 345,129 (+9.01%) | Filing History |
| 2022-02-04 09:29 am Sale | 2021-12-31 | 13G | Revance Therapeutics, Inc. RVNC | WELLINGTON MANAGEMENT CO LLP | 1,104,531 1.540% | -2,293,341 (-67.49%) | Filing History |